UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Telaprevir impairs renal function and increases blood ribavirin concentration during telaprevir/pegylated interferon/ribavirin therapy for chronic hepatitis C

Journal of viral hepatitis, 2014-05, Vol.21 (5), p.341-347

2014

Volltextzugriff (PDF)

963 SAFETY AND A ANTIVIRAL ACTIVITY OF A MONOTHERAPY WITH A MP-424 FOR 24 WEEKS IN NAIVE PATIENTS WITH CHRONIC HEPATITIS C VIRUS GENOTYPE 1B INFECTION

Journal of hepatology, 2009, Vol.50, p.S350-S350

Ozeki, I

2009

Volltextzugriff (PDF)

Analysis of Hepatitis B Surface Antigen (HBsAg) Levels Using the Highly Sensitive Lumipulse HBsAg-HQ Assay in Hepatitis B Virus Patients with HBsAg Seroclearance According to the Conventional Assay

Journal of hepatology, 2016, Vol.64 (2), p.S592-S592

2016

Volltextzugriff (PDF)

P0997 : WFA+-M2BP is a predictive factor for fibrosis progression in NAFLD

Journal of hepatology, 2015-04, Vol.62, p.S721-S721

2015

Volltextzugriff (PDF)

The Real World Experience of Daclatasvir and Asunaprevir Combination Therapy for More Elderly Patients thanthe Clinical Trial Subjects with Genotype 1b Chronic Hepatitis C

Journal of hepatology, 2016, Vol.64 (2), p.S819-S819

2016

Volltextzugriff (PDF)

Preparation of single-helix carbon microcoils by catalytic CVD process

Thin solid films, 2008-01, Vol.516 (5), p.718-721

2008

Volltextzugriff (PDF)

825 ANALYSIS OF THE OPTIMAL TVR DOSE PER WEIGHT JUDGING FROM ANEMIA DURING PEG-IFN/RBV/TVR COMBINATION THERAPY

Journal of hepatology, 2013-04, Vol.58, p.S338-S338

2013

Volltextzugriff (PDF)

Virological response and safety of 24-week telaprevir alone in Japanese patients infected with hepatitis C virus subtype 1b

Journal of viral hepatitis, 2013-03, Vol.20 (3), p.167-173

2013

Volltextzugriff (PDF)

Detection of hypermethylation of the p16(INK4A) gene promoter in chronic hepatitis and cirrhosis associated with hepatitis B or C virus

Gut, 2001-03, Vol.48 (3), p.372-377

2001

Volltextzugriff (PDF)

1124 2250MG/DAY OF TELAPREVIR DOSAGE IMPAIR THE RIBAVIRIN DOSAGE AND CLINICAL EFFECT OF TRIPLE THERAPY IN THE PATIENTS WITH A LOW TOTAL CLEARANCE OF RIBAVIRIN

Journal of hepatology, 2012-04, Vol.56, p.S443-S443

2012

Volltextzugriff (PDF)

835 RBV BLOOD CONCENTRATION AT FIRST WEEK OF PEG-IFN/RBV/TVR COMBINATION THERAPY IS A GOOD PREDICTIVE MARKER OF RENAL DYSFUNCTION AND ANEMIA

Journal of hepatology, 2013-04, Vol.58, p.S342-S343

2013

Volltextzugriff (PDF)

1330 IL28B GENOTYPE MAJOR AND RELAPSE OF PREVIOUS PEG-IFN/RBV THERAPY ARE THE CONVINCING PREDICTOR OF SUSTAINED VIROLOGICAL RESPONSE IN TELAPREVIR WITH PEG-IFN/RBV THERAPY

Journal of hepatology, 2011-03, Vol.54, p.S525-S525

2011

Volltextzugriff (PDF)

Stimulated Raman Scattering Microscopy: Techniques and Applications

1, 2021

Volltextzugriff (PDF)

268 RELATIONSHIP OF SERUM IP-10 LEVELS WHICH REFLECTS HEPATIC INTERFERON STIMULATING GENE INDUCTION AND ANTIVIRAL EFFECT OF PEG/RBV COMBINATION THERAPY IN PATIENT WITH CHRONIC HEPATITIS C

Journal of hepatology, 2010, Vol.52, p.S112-S113

2010

Volltextzugriff (PDF)

Characterization of α-Glucosidase Inhibitor/Cyclodextrin Complex Prepared by Freeze-Drying

Journal of Pharmaceutics, 2018-01, Vol.2018, p.3202719-9

2018

Volltextzugriff (PDF)

799 TIMING OF HCV NEGATIVITY AND POSSIBLE SVR MAY BE PREDICTABLE BY HCVRNA LEVELS MEASURED WITH TAQMAN HCV IN EARLY TREATMENT PHASE

Journal of hepatology, 2008, Vol.48, p.S298-S298

2008

Volltextzugriff (PDF)

Evaluation between the Usability and Physicochemical Property of Acyclovir Ointments

Journal of Pharmaceutics, 2018-01, Vol.2018, p.8761394-8

2018

Volltextzugriff (PDF)

Marine Glycomics

2022

Volltextzugriff (PDF)

Recent steroid use and the relapse risk in ulcerative colitis patients with endoscopic healing

Alimentary pharmacology & therapeutics, 2024-07, Vol.60 (1), p.43-51

2024

Volltextzugriff (PDF)

FRI-122 - Analysis of Hepatitis B Surface Antigen (HBsAg) Levels Using the Highly Sensitive Lumipulse HBsAg-HQ Assay in Hepatitis B Virus Patients with HBsAg Seroclearance According to the Conventional Assay

Journal of hepatology, 2016, Vol.64 (2), p.S592-S592

2016

Volltextzugriff (PDF)

P1216 EFFICACY AND SAFETY OF SIMEPREVIR PLUS PEG-INTERFERON/RIBAVIRIN THERAPY IN PATIENTS WITH HCV GENOTYPE 1 – COMPARISON WITH TELAPREVIR PLUS PEG-INTERFERON/RIBAVIRIN THERAPY AND PEG-INTERFERON/RIBAVIRIN THERAPY

Journal of hepatology, 2014-04, Vol.60 (1), p.S494-S494

2014

Volltextzugriff (PDF)

Improving polygenic prediction in ancestrally diverse populations

Nature genetics, 2022-05, Vol.54 (5), p.573-580

2022

Volltextzugriff (PDF)

FRI-384 - Recurrence of hepatocellular carcinoma in patients with a history of HCC after SVR to DAA for chronic hepatitis C

Journal of hepatology, 2018-04, Vol.68, p.S535-S535

2018

Volltextzugriff (PDF)

Recurrence of hepatocellular carcinoma in patients with a history of HCC after SVR to DAA for chronic hepatitis C

Journal of hepatology, 2018-04, Vol.68, p.S535

2018

Volltextzugriff (PDF)

Determination of the optimum timing of the start of nucleoside analogue by FIB-4 index for hepatitis B patients from the viewpoint of suppressing hepatocarcinogenesis

Journal of hepatology, 2018-04, Vol.68, p.S511

2018

Volltextzugriff (PDF)

1 – 25 von 6.650

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(4.733)
Mit Volltextzugriff
(5.314)

Publikationsform

6 weitere anzeigen...

Weniger anzeigen...

Sprache

2 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Kollektion

EZB Electronic Journals Library
(2.597)
Ingenta
(2.138)
MEDLINE
(1.807)
Access via ScienceDirect (Elsevier)
(1.061)
Journals@Ovid
(1.033)
Elsevier Journal Backfiles on ScienceDirect (DFG Nationallizenzen)
(878)
Publisher website
(747)
Wiley Online Library
(693)
SpringerLink
(575)
IngentaConnect Journals
(548)
SpringerLINK Contemporary (Konsortium Baden-Württemberg)
(414)
Wiley Online Library
(405)
IEEE Electronic Library Online
(396)
Oxford journals
(226)
Taylor & Francis Online
(153)
Taylor & Francis
(151)
Taylor & Francis Journals
(148)
AIP Scitation Journals Complete
(128)
Nature Journals
(118)
Ebook Central Perpetual and DDA
(102)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

Menü

Weitere Dienste

Einstellungen

Telaprevir impairs renal function and increases blood ribavirin concentration during telaprevir/pegylated interferon/ribavirin therapy for chronic hepatitis C

963 SAFETY AND A ANTIVIRAL ACTIVITY OF A MONOTHERAPY WITH A MP-424 FOR 24 WEEKS IN NAIVE PATIENTS WITH CHRONIC HEPATITIS C VIRUS GENOTYPE 1B INFECTION

Analysis of Hepatitis B Surface Antigen (HBsAg) Levels Using the Highly Sensitive Lumipulse HBsAg-HQ Assay in Hepatitis B Virus Patients with HBsAg Seroclearance According to the Conventional Assay

P0997 : WFA+-M2BP is a predictive factor for fibrosis progression in NAFLD

The Real World Experience of Daclatasvir and Asunaprevir Combination Therapy for More Elderly Patients thanthe Clinical Trial Subjects with Genotype 1b Chronic Hepatitis C

Preparation of single-helix carbon microcoils by catalytic CVD process

825 ANALYSIS OF THE OPTIMAL TVR DOSE PER WEIGHT JUDGING FROM ANEMIA DURING PEG-IFN/RBV/TVR COMBINATION THERAPY

Virological response and safety of 24-week telaprevir alone in Japanese patients infected with hepatitis C virus subtype 1b

Detection of hypermethylation of the p16(INK4A) gene promoter in chronic hepatitis and cirrhosis associated with hepatitis B or C virus

1124 2250MG/DAY OF TELAPREVIR DOSAGE IMPAIR THE RIBAVIRIN DOSAGE AND CLINICAL EFFECT OF TRIPLE THERAPY IN THE PATIENTS WITH A LOW TOTAL CLEARANCE OF RIBAVIRIN

835 RBV BLOOD CONCENTRATION AT FIRST WEEK OF PEG-IFN/RBV/TVR COMBINATION THERAPY IS A GOOD PREDICTIVE MARKER OF RENAL DYSFUNCTION AND ANEMIA

1330 IL28B GENOTYPE MAJOR AND RELAPSE OF PREVIOUS PEG-IFN/RBV THERAPY ARE THE CONVINCING PREDICTOR OF SUSTAINED VIROLOGICAL RESPONSE IN TELAPREVIR WITH PEG-IFN/RBV THERAPY

Stimulated Raman Scattering Microscopy: Techniques and Applications

268 RELATIONSHIP OF SERUM IP-10 LEVELS WHICH REFLECTS HEPATIC INTERFERON STIMULATING GENE INDUCTION AND ANTIVIRAL EFFECT OF PEG/RBV COMBINATION THERAPY IN PATIENT WITH CHRONIC HEPATITIS C

Characterization of α-Glucosidase Inhibitor/Cyclodextrin Complex Prepared by Freeze-Drying

799 TIMING OF HCV NEGATIVITY AND POSSIBLE SVR MAY BE PREDICTABLE BY HCVRNA LEVELS MEASURED WITH TAQMAN HCV IN EARLY TREATMENT PHASE

Evaluation between the Usability and Physicochemical Property of Acyclovir Ointments

Marine Glycomics

Recent steroid use and the relapse risk in ulcerative colitis patients with endoscopic healing

FRI-122 - Analysis of Hepatitis B Surface Antigen (HBsAg) Levels Using the Highly Sensitive Lumipulse HBsAg-HQ Assay in Hepatitis B Virus Patients with HBsAg Seroclearance According to the Conventional Assay

P1216 EFFICACY AND SAFETY OF SIMEPREVIR PLUS PEG-INTERFERON/RIBAVIRIN THERAPY IN PATIENTS WITH HCV GENOTYPE 1 – COMPARISON WITH TELAPREVIR PLUS PEG-INTERFERON/RIBAVIRIN THERAPY AND PEG-INTERFERON/RIBAVIRIN THERAPY

Improving polygenic prediction in ancestrally diverse populations

FRI-384 - Recurrence of hepatocellular carcinoma in patients with a history of HCC after SVR to DAA for chronic hepatitis C

Recurrence of hepatocellular carcinoma in patients with a history of HCC after SVR to DAA for chronic hepatitis C

Determination of the optimum timing of the start of nucleoside analogue by FIB-4 index for hepatitis B patients from the viewpoint of suppressing hepatocarcinogenesis

Suchergebnisse filtern